# FDA Approves Aurobindo Pharma Generic Drug Application Aurobindo Pharma Ltd has received FDA approval for its abbreviated new drug application (ANDA210386), positioning the Indian pharmaceutical manufacturer to capture generic market share in a competitive therapeutic segment. The approval represents another step in Aurobindo's strategy to expand its U.S. presence and diversify its generic drug portfolio.